Calcitonin: A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.Calcitonin Gene-Related Peptide: Calcitonin gene-related peptide. A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.Receptors, Calcitonin: Cell surface proteins that bind calcitonin and trigger intracellular changes which influence the behavior of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood.Receptors, Calcitonin Gene-Related Peptide: Cell surface proteins that bind CALCITONIN GENE-RELATED PEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells. CGRP receptors are present in both the CENTRAL NERVOUS SYSTEM and the periphery. They are formed via the heterodimerization of the CALCITONIN RECEPTOR-LIKE PROTEIN and RECEPTOR ACTIVITY-MODIFYING PROTEIN 1.Calcitonin Receptor-Like Protein: A receptor protein that is associated with RECEPTOR ACTIVITY-MODIFYING PROTEINS. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 1 it forms the CALCITONIN GENE-RELATED RECEPTOR. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3 it forms the ADRENOMEDULLIN RECEPTOR.Receptor Activity-Modifying Proteins: A family of proteins that bind to CELL SURFACE RECEPTORS and alter their specificity, signaling mechanism, or mode of intracellular transport.Receptor Activity-Modifying Protein 1: A receptor activity-modifying protein that is a subunit of specific G-PROTEIN COUPLED RECEPTORS. The CALCITONIN GENE-RELATED PEPTIDE RECEPTOR is formed from a dimer of this protein and CALCITONIN RECEPTOR-LIKE PROTEIN, while an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.Adrenomedullin: A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion.Salmon: Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed).Receptor Activity-Modifying Protein 2: A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.Receptor Activity-Modifying Protein 3: A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.Receptors, Islet Amyloid Polypeptide: G-protein coupled receptors that are formed through the dimerization of the CALCITONIN RECEPTOR with a RECEPTOR ACTIVITY-MODIFYING PROTEIN. Their affinity for ISLET AMYLOID POLYPEPTIDE is dependent upon which of several receptor activity-modifying protein subtypes they are bound to.Substance P: An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.Receptors, Adrenomedullin: G-protein-coupled cell surface receptors for ADRENOMEDULLIN. They are formed by the heterodimerization of CALCITONIN RECEPTOR-LIKE PROTEIN and either RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3.Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)Capsaicin: An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.Neuropeptides: Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells.Ultimobranchial Body: A diverticulum from the fourth pharyngeal pouch of an embryo, regarded by some as a rudimentary fifth pharyngeal pouch and by others as a lateral thyroid primordium. The ultimobranchial bodies of lower vertebrates contain large amounts of calcitonin. In mammals the bodies fuse with the thyroid gland and are thought to develop into the parafollicular cells. (Stedman, 25th ed)Eels: Common name for an order (Anguilliformes) of voracious, elongate, snakelike teleost fishes.Osteitis Deformans: A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.Thyroidectomy: Surgical removal of the thyroid gland. (Dorland, 28th ed)Parathyroid Hormone: A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.Pentagastrin: A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.Cyclic AMP: An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.Miotics: Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.Thyroid Gland: A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.Receptors, Peptide: Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells.Islet Amyloid Polypeptide: A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.Rats, Sprague-Dawley: A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.Bone Resorption: Bone loss due to osteoclastic activity.Neurons, Afferent: Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM.Radioimmunoassay: Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.Trigeminal Ganglion: The semilunar-shaped ganglion containing the cells of origin of most of the sensory fibers of the trigeminal nerve. It is situated within the dural cleft on the cerebral surface of the petrous portion of the temporal bone and gives off the ophthalmic, maxillary, and part of the mandibular nerves.Calcium: A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)Osteoclasts: A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.Vasoactive Intestinal Peptide: A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).Ganglia, Spinal: Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain.Calcium Gluconate: The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states.Peptide Fragments: Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.Nerve Fibers: Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM.Bone Density Conservation Agents: Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Trigeminal Nerve: The 5th and largest cranial nerve. The trigeminal nerve is a mixed motor and sensory nerve. The larger sensory part forms the ophthalmic, mandibular, and maxillary nerves which carry afferents sensitive to external or internal stimuli from the skin, muscles, and joints of the face and mouth and from the teeth. Most of these fibers originate from cells of the TRIGEMINAL GANGLION and project to the TRIGEMINAL NUCLEUS of the brain stem. The smaller motor part arises from the brain stem trigeminal motor nucleus and innervates the muscles of mastication.Neurokinin A: A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.RNA, Messenger: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.Peptides: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.Rats, Wistar: A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.Neuropeptide Y: A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.Hypercalcemia: Abnormally high level of calcium in the blood.Vasodilation: The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.Bone and Bones: A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)Hormones, Ectopic: Hormones released from neoplasms or from other cells that are not the usual sources of hormones.

*  Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count | Archives of Disease...
A polypeptide identical to a prohormone of calcitonin, procalcitonin, was initially described as a potential marker of ...
  http://adc.bmj.com/content/81/5/417.full
*  FRMC Pharmacist Published With Procalcitonin Study
Procalcitonin (PCT) is a Peptide Precursor of the hormone Calcitonin. The level of Procalcitonin will rise in the presence of a ...
  http://www.fiveriversmc.com/2017/11/frmc-pharmacist-gets-published-nationally/
*  Patent US3926938 - Synthesis of salmon calcitonin - Google Patents
... also embraces peptides from which the resin moiety has been cleaved and which are useful in the synthesis of salmon calcitonin ... Resin peptides useful in the preparation of salmon calcitonin are disclosed along with processes for preparing the same. The ... Glycine-8 calcitonin. WO1996024618A1 *. Feb 2, 1996. Aug 15, 1996. Therapicon S.R.L.. Calcitonin salmon analogues, their ... 16-Alanine]calcitonin. US4663309 *. Jun 28, 1984. May 5, 1987. University Patents, Inc.. Novel peptide hormones with calcitonin ...
  http://www.google.com/patents/US3926938?dq=7751826
*  Calcitonin, Ultra-Sensitive RIA Test
The major action of calcitonin is to lower plasma calcium concentrations, by inhibiting osteoclast activity, resulting in ... Calcitonin is synthesized in the parafollicular C-cells of the thyroid gland and is packaged in secretory granules. ... Elevated serum calcitonin levels may also occur in a variety of other malignancies, possibly due to ectopic calcitonin ... following exogenous administration of calcitonin. Exogenously administered calcitonin has also been shown to reduce pain ...
  http://www.bio-medicine.org/medicine-products/Calcitonin--Ultra-Sensitive-RIA-Test-11850-1/
*  APO-Calcitonin synonyms, APO-Calcitonin antonyms - FreeThesaurus.com
Antonyms for APO-Calcitonin. 1 synonym for calcitonin: thyrocalcitonin. What are synonyms for APO-Calcitonin? ... calcitonin. (redirected from APO-Calcitonin). Also found in: Dictionary, Medical, Encyclopedia.. Related to APO-Calcitonin: ... APO-Calcitonin synonyms, APO-Calcitonin antonyms - FreeThesaurus.com https://www.freethesaurus.com/APO-Calcitonin ... Synonyms for calcitonin. thyroid hormone that tends to lower the level of calcium in the blood plasma and inhibit resorption of ...
  https://www.freethesaurus.com/APO-Calcitonin
*  Further studies on the mode of action of calcitonin on isolated rat osteoclasts: pharmacological evidence for a second site...
Furthermore, the peptides, when used at a 50-fold higher molar concentration than calcitonin, did not antagonize calcitonin- ... Two structurally related members of the calcitonin gene peptide family, calcitonin gene-related peptide (CGRP) and amylin, ... unlike calcitonin, the non-calcitonin Q effect agonists did not produce a rise in [Ca2+]i. The peptides were also unable to ... This site can be activated by nanomolar concentrations of calcitonin, amylin, CGRP or CGRP-(Val8Phe37). A novel R effect site, ...
  https://www.ndorms.ox.ac.uk/publications/475698
*  Calcitonin Related Peptides
Calcitonin contains a single disulfide bond, which causes the amino terminus to assume the shape of a ring. The calcitonin ... An increase in the serum calcium level is known to stimulate calcitonin secretion. In mammals, the major source of calcitonin ... Calcitonin gene-related peptide (CGRP), adrenomedullin (ADM) and amylin belong to a unique group of calcitonin-related peptide ... Calcitonin, a 32-amino acid peptide hormone, is essential for calcium balance, whereas CGRP and ADM are important for ...
  https://www.anaspec.com/products/productcategory.asp?id=157
*  SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study - Full Text...
Salmon calcitonin. Calcitonin. Calcitonin Gene-Related Peptide. Bone Density Conservation Agents. Physiological Effects of ... The purpose of this study is to expose patients with OA to calcitonin and to determine plasma calcitonin levels after ... Also the purpose is to assess the effect of different doses of oral calcitonin (0.6 mg and 0.8 mg oral) compared to placebo on ... Karsdal MA, Byrjalsen I, Henriksen K, Riis BJ, Lau EM, Arnold M, Christiansen C. The effect of oral salmon calcitonin delivered ...
  https://clinicaltrials.gov/ct2/show/NCT00486369
*  Calcitonin
... is a hormone produced by special cells in the thyroid called C-cells and excessive amounts are produced in these two ... The calcitonin test is primarily used to help diagnose and monitor treatment of C-cell hyperplasia and medullary thyroid cancer ... In some cases, calcitonin levels will fall but remain moderately elevated after treatment. This means that some calcitonin- ... This test measures the amount of calcitonin in the blood.. Calcitonin is involved in the regulation of calcium levels in the ...
  https://labtestsonline.org/tests/calcitonin
*  Calcitonin | hormone | Britannica.com
Calcitonin, a protein hormone synthesized and secreted in humans and other mammals primarily by parafollicular cells (C cells) ... Both increased calcitonin secretion and increased calcitonin activity are relatively short-lived, lasting only a few days. As a ... thyroid gland: The thyroid gland and calcitonin. …adults. The thyroid gland is also the site of the production of calcitonin, a ... hormone: Ultimobranchial tissue and calcitonin. …enzyme synthesis. The discovery of calcitonin (thyrocalcitonin) in 1961 ...
  https://www.britannica.com/science/calcitonin-hormone
*  calcitonin - Everything2.com
Calcitonin is a hormone which is released by the thyroid and parathyroid glands when the levels of calcium compounds in the ... Calcitonin is a hormone which is released by the thyroid and parathyroid glands when the levels of calcium compounds in the ... A calcitonin molecule is a small peptide composed of thirty-two amino acids. ...
  https://everything2.com/title/calcitonin
*  Calcitonin IRMA Test
The major action of calcitonin is to lower plasma calcium concentrations, by inhibiting osteoclast activity, resulting in ... Calcitonin is synthesized in the parafollicular C-cells of the thyroid gland and is packaged in secretory granules. ... Calcitonin RIA Kit. 3. Nichols Advantage® Calcitonin Assay. 4. Calcitonin RIA Test. 5. Calcitonin, Ultra-Sensitive RIA Test. 6 ... Calcitonin Assay Immunoradiometric (IRMA) Assay. 7. Calcitonin Microwell-EIA. 8. Calcitonin ELISA. 9. Calcitonin. ...
  http://www.bio-medicine.org/medicine-products/Calcitonin-IRMA-Test-18510-1/
*  calcitonin (thing) by BioTech - Everything2.com
Calcitonin is a hormone which is released by the thyroid and parathyroid glands when the levels of calcium compounds in the ... calcitonin (thing). See all of calcitonin, no other writeups in this node. ... Calcitonin is a hormone which is released by the thyroid and parathyroid glands when the levels of calcium compounds in the ... A calcitonin molecule is a small peptide composed of thirty-two amino acids. ...
  https://everything2.com/user/BioTech/writeups/calcitonin
*  Women's Health Matters - Calcitonin
Calcitonin. Calcitonin is a hormone that occurs naturally in your body. It is secreted by the thyroid gland, and helps regulate ... Calcitonin nasal spray. Calcitonin nasal spray, available in Canada as Miacalcin®, is approved for the treatment of ... If you are pregnant or breastfeeding, you should not use calcitonin.. Cost. Coverage of calcitonin varies from province to ... Calcitonin injection. Calcitonin injection is currently not approved for the treatment of osteoporosis but is sometimes ...
  http://www.womenshealthmatters.ca/health-centres/bone-joint-health/treatment/calcitonin/
*  calcitonin gene-related peptide | Modern medicine
Home , About us , Contact us , Advertise , All Content , Editorial and Advertising Policy , Terms and Conditions , Privacy Policy , Terms of Use , Advertiser Terms , Linking and RSS policy. © 2018 UBM Medica, LLC, a UBM company. Reproduction in whole or in part is prohibited.. Please send any technical comments or questions to our webmaster.. ...
  http://www.modernmedicine.com/tag/calcitonin-gene-related-peptide
*  026781: Calcitonin (Thyrocalcitonin), Three Specimens | LabCorp
Calcitonin, Serum (3 Spec). 019859. Tube ID #3. N/A. 026781. Calcitonin, Serum (3 Spec). 026793. Calcitonin (3 Specimens). N/A ... Calcitonin, Serum (3 Spec). 019848. Calcitonin #1. pg/mL. 58892-1. 026781. Calcitonin, Serum (3 Spec). 019857. Tube ID #1. N/A ... Calcitonin, Serum (3 Spec). 019851. Calcitonin #2. pg/mL. 33788-1. 026781. Calcitonin, Serum (3 Spec). 019858. Tube ID #2. N/A ...
  https://www.labcorp.com/test-menu/21591/calcitonin-thyrocalcitonin-three-specimens
*  048249: Calcitonin (Thyrocalcitonin), Two Specimens | LabCorp
Calcitonin, Serum (2 Spec). 019858. Tube ID #2. N/A. 048249. Calcitonin, Serum (2 Spec). 048262. Calcitonin (2 Specimens). N/A ... Calcitonin, Serum (2 Spec). 019848. Calcitonin #1. pg/mL. 58892-1. 048249. Calcitonin, Serum (2 Spec). 019857. Tube ID #1. N/A ...
  https://www.labcorp.com/test-menu/21586/calcitonin-thyrocalcitonin-two-specimens
*  Intranasal calcitonin and plasma calcium concentrations. | The BMJ
Intranasal calcitonin and plasma calcium concentrations. Br Med J (Clin Res Ed) 1985; 291 :544 ... Intranasal calcitonin and plasma calcium concentrations.. Br Med J (Clin Res Ed) 1985; 291 doi: https://doi.org/10.1136/bmj. ...
  http://www.bmj.com/content/291/6494/544.4
*  Calcitonin receptor antibodies in... preview & related info | Mendeley
Only the calcitonin receptor (CTR) expression unambiguously identifies osteoclasts and distinguishes them from macrophage ... Autoradiographic detection of125I-labeled salmon calcitonin combined with CTR immunohistochemistry showed that both methods ...
  https://www.mendeley.com/research-papers/calcitonin-receptor-antibodies-identification-osteoclasts/
*  Osteoporosis drug calcitonin linked to cancer risk | EmaxHealth
Calcitonin, also called calcitonin-salmon, is a synthetic copy of a polypeptide hormone secreted by the ultimobranchial gland ... Calcitonin is a hormone that increases the amount of calcium in the bones and lowers the calcium level in the blood. ... CHMP concluded that the benefits of calcitonin for osteoporosis did not exceed the risks. The committee noted that the spray's ... In addition to banning its use for osteoporosis, the CHMP recommended that calcitonin should be administered for no more than ...
  https://www.emaxhealth.com/11306/osteoporosis-drug-calcitonin-linked-cancer-risk
*  Acute responsiveness to calcitonin in chronic renal failure. | The BMJ
In 11 patients fasting plasma calcitonin levels were undetectable with an assay sensitive to 0-1 mug/1. Calcitonin seems to ... The acute effect of porcine calcitonin was tested in 17 patients undergoing chronic haemodialysis. In normal adults calcitonin ... Acute responsiveness to calcitonin in chronic renal failure. Br Med J 1976; 2 :396 ... Plasma hydroxyproline levels were not significantly different in the two groups an were unaffected by calcitonin. ...
  http://www.bmj.com/content/2/6032/396
*  Adcoms Recommend Higher Standards for Calcitonin Drugs | BioWorld
Drugmakers with calcitonin salmon products under development for postmenopause osteoporosis (PMO) may have to do a lot more ...
  http://www.bioworld.com/content/adcoms-recommend-higher-standards-calcitonin-drugs

Procalcitonin: Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, the latter being involved with calcium homeostasis. It is composed of 116 amino acids and is produced by parafollicular cells (C cells) of the thyroid and by the neuroendocrine cells of the lung and the intestine.Calcitonin gene-related peptide receptor antagonist: Calcitonin gene-related peptide (CGRP) receptor antagonists are a class of drugs that act as antagonists of the calcitonin gene-related peptide receptor (CGRPR). Some examples include olcegepant, telcagepant, and ubrogepant.Adrenomedullin: Adrenomedullin (ADM or AM) is a vasodilator peptide hormone of uncertain significance in human health and disease. It was initially isolated in 1993 from pheochromyctoma, a tumor of the adrenal medulla: hence the name.Diseases and parasites in salmonAutopharmacology: Autopharmacology relates to the scientific study of the regulation of body functions by the activity of its naturally existent (or endogenous) chemical factors of the tissues. A more restricted definition would consider substances that were first identified as external agents which had a documented action on physiological functions, but later were discovered as existing as endogenous factors.GPR182: GPR182 (or G protein-coupled receptor 182) is a human gene (and associated protein) which is an orphan G-protein coupled receptor.Medullary carcinoma: Medullary carcinoma refers to one of several tumors.DihydrocapsaicinThyroid cancerNeuropeptide S: Neuropeptide S (NPS) is a neuropeptide found in human and mammalian brain, mainly produced by neurons in the amygdala and between Barrington's nucleus and the locus coeruleus, although NPS-responsive neurons extend projections into many other brain areas. NPS binds specifically to a newly de-orphaned G protein-coupled receptor, NPSR.Ultimopharyngeal body: The ultimopharyngeal body or ultimobranchial body or ultimobranchial gland is a small organ found in the neck region of many animals.Mycobacterium montefiorense: Mycobacterium montefiorense has been demonstrated to be an etiologic agent of a granulomatous skin disease of moray eels. Sequence analysis, of the 16S rRNA gene reveals M.PagetThyroidectomyParathyroid hormone family: The parathyroid hormone family is a family of structurally and functionally related proteins. Parathyroid hormone (PTH) is a polypeptidic hormone primarily involved in calcium metabolism.PentagastrinCrosstalk (biology): Biological crosstalk refers to instances in which one or more components of one signal transduction pathway affects another. This can be achieved through a number of ways with the most common form being crosstalk between proteins of signalling cascades.Follicular cellAmylin family: In molecular biology, the amylin protein family or calcitonin/CGRP/IAPP protein family is a family of proteins, which includes the precursors of calcitonin/calcitonin gene-related peptide (CGRP), islet amyloid polypeptide (IAPP) and adrenomedullin.DeoxypyridinolineCalcium signaling: Calcium ions are important for cellular signalling, as once they enter the cytosol of the cytoplasm they exert allosteric regulatory effects on many enzymes and proteins. Calcium can act in signal transduction resulting from activation of ion channels or as a second messenger caused by indirect signal transduction pathways such as G protein-coupled receptors.Hypomagnesemia with secondary hypocalcemia: Hypomagnesemia with secondary hypocalcemia (HSH) is an autosomal recessive genetic disorder affecting intestinal magnesium absorption. Decreased intestinal magnesium reabsorption and the resulting decrease in serum magnesium levels is believed to cause lowered parathyroid hormone (PTH) output by the parathyroid gland.OsteoclastVasoactive intestinal peptide: Vasoactive intestinal peptide also known as the vasoactive intestinal polypeptide or VIP is a peptide hormone containing 28 amino acid residues.HyperkalemiaNerve fiber layer: The retinal nerve fiber layer (nerve fiber layer, stratum opticum, RNFL) is formed by the expansion of the fibers of the optic nerve; it is thickest near the porus opticus, gradually diminishing toward the ora serrata.Concentration effect: In the study of inhaled anesthetics, the concentration effect is the increase in the rate that the Fa(alveolar concentration)/Fi(inspired concentration) ratio rises as the alveolar concentration of that gas is increased. In simple terms, the higher the concentration of gas administered, the faster the alveolar concentration of that gas approaches the inspired concentration.Trigeminovascular system: The trigeminovascular system consists of neurons in the trigeminal nerve that innervate cerebral blood vessels. It has been hypothesized that the trigeminovascular system may be involved in some types of headaches.Mature messenger RNA: Mature messenger RNA, often abbreviated as mature mRNA is a eukaryotic RNA transcript that has been spliced and processed and is ready for translation in the course of protein synthesis. Unlike the eukaryotic RNA immediately after transcription known as precursor messenger RNA, it consists exclusively of exons, with all introns removed.HydroxyprolineSEA Native Peptide LigationFamilial hypocalciuric hypercalcemiaVasodilation: Vasodilation (or vasodilatation) refers to the widening of blood vessels. It results from relaxation of smooth muscle cells within the vessel walls, in particular in the large veins, large arteries, and smaller arterioles.Cancellous bone: Cancellous bone, synonymous with trabecular bone or spongy bone, is one of two types of osseous tissue that form bones. The other osseous tissue type is cortical bone also called compact bone.Migraine Disability Assessment Test: The MIDAS or Migraine Disability Assessment Test is a test used by doctors to determine how severely migraines affect a patient's life. Patients are asked questions about the frequency and duration of their headaches, as well as how often these headaches limited their ability to participate in activities at work, at school, or at home.

(1/1409) Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus.

Estrogen is known to increase progesterone receptor (PR) levels in the wild-type mouse uterus, and this estrogen induction was thought to be important for progesterone action through the PR. The estrogen receptor alpha knockout (ERKO) mouse uterus was observed to express PR mRNA that cannot be induced by estrogen. Progesterone action was characterized to determine whether it was diminished in ERKO mice. The PR protein is present in the ERKO uterus at 60% of the level measured in a wild-type uterus. The PR-A and PR-B isoforms are both detected on Western blot, and the ratio of isoforms is the same in both genotypes. Although the level of PR is reduced in the ERKO uterus, the receptor level is sufficient to induce genomic responses, since both calcitonin and amphiregulin mRNAs were increased after progesterone treatment. Finally, the ERKO uterus can be induced to undergo a progesterone-dependent decidual response. Surprisingly, the decidual response is estrogen independent in the ERKO, although it remains estrogen dependent in a wild type. These results indicate that estrogen receptor alpha modulation of PR levels is not necessary for expression of the PR or genomic and physiologic responses to progesterone in the ERKO uterus.  (+info)

(2/1409) A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.

Transplantation of solid organs including heart, kidney, and liver is associated with rapid bone loss and increased rate of fracture; data on bone marrow transplantation recipients (BMT) are scarce. The purpose of the present study was to examine the magnitude, timing, and mechanism of bone loss following allogeneic BMT, and to study whether bone loss can be prevented by calcium with or without calcitonin. Sixty-nine patients undergoing allogeneic BMT for malignant blood diseases were enrolled into the study. Forty-four (22 women, 22 men) completed 6 months, and 36 patients 1 year follow-up. They were randomized to receive either no additional treatment (n = 22), or oral calcium 1 g twice daily for 12 months (n = 12) or the same dose of calcium plus intranasal calcitonin 400 IU/day for the first month and then 200 IU/day for 11 months (n = 10). Bone mineral density (BMD) at the lumbar spine and three femoral sites (femoral neck, trochanter, Ward's triangle) was measured by dual-energy X-ray absorptiometry (DXA). Bone turnover rate was followed with markers of bone formation and resorption (serum bone-specific alkaline phosphatase (B-ALP), type I procollagen carboxyterminal (PICP) and aminoterminal propeptide (PINP), serum type I collagen carboxyterminal telopeptide (ICTP)). Serum testosterone was assayed in men. Calcium with or without calcitonin had no effect on bone loss or bone markers; consequently the three study groups were combined. During the first 6 post-transplant months BMD decreased by 5.7% in the lumbar spine and by 6.9% to 8.7% in the three femoral sites (P < 0.0001 for all); no significant further decline occured between 6 and 12 months. Four out of 25 assessable patients experienced vertebral compression fractures. Markers of bone formation reduced: B-ALP by 20% at 3 weeks (P = 0.027), PICP by 40% (P < 0.0001) and PINP by 63% at 6 weeks (P < 0.0001), with a return to baseline by 6 months. The marker of bone resorption, serum ICTP was above normal throughout the whole observation period, with a peak at 6 weeks (77% above baseline, P < 0.0001). In male patients serum testosterone decreased reaching a nadir (57% below baseline) at 6 weeks (P = 0.0003). In conclusion, significant bone loss occurs after BMT. It results from imbalance between reduced bone formation and increased bone resorption; hypogonadism may be a contributing factor in men. Bone loss can not be prevented by calcium with or without calcitonin.  (+info)

(3/1409) Study of the cell biology and biochemistry of cherubism.

AIMS: To establish whether the multinucleate cells in lesions of patients with cherubism are also osteoclasts and if this is the case whether they were responsive to calcitonin; to carry out cytogenetic studies on two members of the same family affected by cherubism in an attempt to identify any major chromosomal defects; and to perform an in-depth modern biochemical study of four children in the same family. SUBJECTS AND METHODS: Four related children with cherubism were studied. Tissue taken from one of the children at elective decompression of an optic nerve was submitted to in vitro bone resorption studies. Cytogenetic studies were done on two of the children and biochemical studies on all four. RESULTS: The multinucleate cells in the cherubic lesions were shown to be osteoclasts since they synthesised tartrate resistant acid phosphatase, expressed the vitronectin receptor, and resorbed bone. Bone resorption by the cultured multinucleate cells was significantly inhibited by calcitonin. High resolution cytogenetic studies failed to detect any chromosomal abnormalities in two children with cherubism. The biochemistry profile of all four children with cherubism showed that serum calcium, parathyroid hormone, parathyroid related hormone, calcitonin, and alkaline phosphatase were within normal levels. Urine analysis of pyridinium and deoxypyridinium cross links, hydroxyproline, and calcium in relation to urine creatinine were measured to assess bone resorption in these children, and the values were at the upper end of the normal range in all four. CONCLUSIONS: Further studies are required to determine whether calcitonin treatment will control this grossly deforming disease until the time when the physiological changes that occur at puberty rectify the pathology. It is not recommended that biochemical markers of bone resorption are used in isolation to monitor the activity of cherubism in individuals because the results are based on a small number of children and because of reports of marked interindividual variation in the levels of these markers, particularly in children.  (+info)

(4/1409) Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma.

Neuroendocrine tumors (NET) of the thyroid gland are rare. Apart from medullary thyroid carcinoma (MTC), metastases of gastroenteropancreatic (GEP) NET may also occur. Features of six patients (five men, one female: age range, 39-67 years) with thyroid metastases from a GEP-NET are described. Thyroid metastases were bilateral in all patients and were associated with enlarged neck lymph nodes in five. In four cases, the thyroid tumor was either the first sign of the disease (n = 2) or was an isolated site of recurrence (n = 2). The tumors were well (n = 3) or poorly differentiated (n = 3). Five tumors for which the primary site could be determined corresponded to foregut-derived tumors (3 lungs, 1 thymus and 1 pancreatic NET). One tumor demonstrated calcitonin (CT) production as shown by immunohistochemistry and elevated plasma CT levels. However, the disease history and the clinical features strongly favored a metastasizing GEP-NET. No tumoral RET proto-oncogene mutation was found in this patient. The differential diagnosis between metastatic GEP-NET and MTC is crucial because prognosis, work-up, and treatment differ greatly.  (+info)

(5/1409) Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.

Carcinoembryonic antigen (CEA) and calcitonin (CT) were simultaneously determined in sera and tumor tissues from 15 patients with medullary carcinoma of the thyroid (MCT). Serum CEA was increased in all but one patient, and CT did in all of them. Both levels were significantly related to the weight of excised tumor, but not to the presence of metastasis. Furthermore, a significant correlation was noted between the basal levels of CT and CEA. Both levels fell to normal after a radical operation had been performed. Tissue concentrations of CEA and CT in the MCT were more than 100 times those in hyperthyroidism, and the ratios of tissue over serum levels averaged 770 in CEA and 1000 in CT. In the calcium infusion test, CEA levels were not significantly changed in contrast with a distinct increase in CT levels. The results indicate that CEA and CT represent separate activities of the tumor cells, and that circulating CEA together with CT is a useful indicator in the diagnosis and follow-up of the disease.  (+info)

(6/1409) Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.

Previously we reported that 8-week treatment with methylprednisolone acetate (MPA: 0.1 mg/kg, s.c., 3 days a week) of male rats caused a novel type of osteopenia whose development was prevented by salmon calcitonin (SCT) in a dose-dependent manner. In this study, to compare the MPA-inducible osteopenia with the ovariectomy (OVX)-inducible one, female rats were used instead of male rats and a time-course study of development was made. MPA treatments for 1, 2, 4 and 8 weeks histologically induced characteristic osteopenic changes in a time-dependent manner that were histomorphometrically detectable in tibiae within 4 weeks as reduced bone mass, accelerated bone resorption, and suppressed bone formation and mineralization. Node-strut analysis revealed that the connectivity of the trabecular structure remained unaffected. Such MPA-induced changes in the trabecular structure, to be defined as thinned-but-uncut, is in a good contrast with OVX-induced unthinned-but-cut structure, although the latter osteopenic changes became detectable 2 weeks earlier. Another previous finding confirmed herein was that MPA-induced osteopenia in female rats was also completely masked by SCT (10 U/kg, s.c., 5 days a week). The results indicate that the MPA-inducible secondary osteopenic model in either sex of rats would be usable for testing anti-osteopenic drugs.  (+info)

(7/1409) Protein kinase C antagonizes pertussis-toxin-sensitive coupling of the calcitonin receptor to adenylyl cyclase.

The calcitonin receptor is known to couple to Gs and Gq, activating adenylyl cyclase and phospholipase C, respectively. The observation of pertussis-toxin-sensitive responses to calcitonin suggests that the receptor is capable of coupling to Gi/o as well. However, the calcitonin-dependent activation of adenylyl cyclase in HEK-293 cells that stably express the cloned rabbit calcitonin receptor, as in many other cells that express calcitonin receptors, shows little pertussis toxin sensitivity. Calcitonin treatment of these cells stimulates protein kinase C, which is reported to antagonize the receptor-dependent activation of Gi. The possibility that protein kinase C could be antagonizing Galphai-adenylyl cyclase coupling was tested by examining the effects of protein kinase C inhibitors (chelerythrine chloride and sphingosine) or of chronic treatment with phorbol ester to deplete protein kinase C. All three treatments led to a reduction of calcitonin-induced adenylyl cyclase activity that was reversed by pertussis toxin. Inhibiting or depleting protein kinase C had no effect on the activation of adenylyl cyclase by cholera toxin, indicating that Gs and adenylyl cyclase were not affected by these treatments. Calcitonin treatment of HEK-293 cells, that stably express a myc-tagged rabbit calcitonin receptor, induced the formation of complexes of the receptor and Galphai subunits, confirming that the calcitonin receptor interacts with Gi. Thus, the calcitonin receptor can couple to Gi, but the inhibition of adenylyl cyclase by Galphai is negatively regulated by protein kinase C.  (+info)

(8/1409) A transient increase in renal clearance of phosphate in response to continuous infusion of salmon calcitonin in rats.

The effects of intravenous carrier-free salmon calcitonin on renal clearances of phosphate, calcium, magnesium, sodium and potassium were studied in male parathyroid-ectomized (PTX) and intact rats. Both natural and synthetic hormone, when infused at constant rates (0.005 approximately 0.5 MRC U/hr), produced a rapid increase (peaking at about 60-90 min) in phosphate clearance. However, the maximal increase was transient in nature in PTX rats. In intact rats, the phosphaturic response was somewhat more pronounced and the decline after the peak was rather modest. When a large amount (4 MRC U) of calcitonin was given in divided doses, the second dose produced a lesser extent of phosphaturia in both intact and PTX rats. The phosphaturic response was accompanied by an increase in sodium and potassium clearances in PTX rats and by an increase in potassium clearance in intact rats. A fall in the apparent clearance values for calcium and magnesium occurred and was maintained throughout the infusion period of hormone in both intact and PTX rats. In conclusion, PTX rats respond to the intravenous administration of salmon calcitonin with a transient phosphaturic response which is accompanied by parallel diuresis of sodium and potassium along with sustained retention of calcium and magnesium by the kidney.  (+info)



  • osteoporosis
  • Synthetic analogues of calcitonin are of particular interest in the treatment of osteoporosis , a disease characterized by the thinning of bones that arises from increased bone resorption or decreased bone formation . (britannica.com)
  • Calcitonin injection is currently not approved for the treatment of osteoporosis but is sometimes prescribed for people who have fractures of the vertebrae, mainly to relieve pain. (womenshealthmatters.ca)
  • The agency also concluded that the benefits of calcitonin-containing medicines did not outweigh their risks in the treatment of osteoporosis and that they should no longer be used for this condition. (emaxhealth.com)
  • CHMP concluded that the benefits of calcitonin for osteoporosis did not exceed the risks. (emaxhealth.com)
  • In addition to banning its use for osteoporosis, the CHMP recommended that calcitonin should be administered for no more than four weeks to prevent acute bone loss resulting from sudden immobilization, and normally for no more than three months to treat Paget's disease. (emaxhealth.com)
  • Calcitonin may be useful in treating various bone disorders including, but not limited to, osteoporosis and Paget's disease. (google.co.uk)
  • gene
  • Calcitonin is formed by the proteolytic cleavage of a larger prepropeptide, which is the product of the CALC1 gene (CALCA). (wikipedia.org)
  • The protein encoded by this gene is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). (wikipedia.org)
  • fishes
  • In birds, fishes, and other nonmammalian vertebrates , calcitonin is secreted by cells of the glandular ultimobranchial bodies. (britannica.com)
  • vasoactive
  • Calcitonin levels may also be increased in association with lung cancer and certain tumours of the pancreas , namely insulinoma (an insulin -secreting tumour) and VIPoma (a vasoactive intestinal polypeptide -secreting tumour). (britannica.com)
  • proteins
  • He also developed novel technologies, in particular intestinal patches, for oral delivery of proteins such as insulin and calcitonin. (wikipedia.org)
  • phosphate
  • Calcitonin seems to have an acute effect in chronic renal failure which may not operate by arresting bone resorption but is dependent on the plasma phosphate concentration. (bmj.com)